SRTA Q2 2024 Earnings — Strata Critical Medical, Inc. Revenue & Financial Results | Market Cap Arena

SRTAStrata Critical Medical, Inc.

$410M

Q2 2024 Earnings

Industrials Airlines, Airports & Air Services

Income Statement

Revenue

$68M+11.4% YoY

Gross Profit

$16M24.1% margin

Operating Income

-$12M-17.9% margin

Net Income

-$11M-16.7% margin

EPS (Diluted)

$-0.15

QoQ Revenue Growth

+31.9%

Cash Flow

Operating Cash Flow

$7M

Free Cash Flow

-$9M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$280M

Total Liabilities

$51M

Stockholders' Equity

$229M

Cash & Equivalents

$26M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$68M	$61M	+11.4%
Gross Profit	$16M	$10M	+57.7%
Operating Income	-$12M	-$12M	+0.5%
Net Income	-$11M	-$12M	+7.4%

Revenue Segments

Medical Segment

$38M56%

Passenger Segment

$30M44%

Geographic Segments

UNITED STATES

$58M85%

Non-US

$10M15%